VATE NYSE Week ended 31 Jul 2026

Weekly Investor Report

Innovate Corp · Industrials · Engineering & Construction

Open interactive chart View report data
Latest close 8.12 USD
-2.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -15.4% below the Trend Line and sits at 24.9% of its 52-week range. The latest completed week returned -2.6%, after a -45.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 1d.

Setup score 31 out of 100
Latest Close 8.12 USD 31 Jul 2026
1W Return -2.6% latest completed week
4W Return -45.2% short-term follow-through
12W Return -30.8% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.6% Latest completed week; four-week move -45.2%. Indicator stack 22/26 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 49/100 48 relevant articles in the latest sentiment read. Event risk 1d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -15.4% below the Trend Line and sits at 24.9% of its 52-week range. The latest completed week returned -2.6%, after a -45.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7712-week average 0.86

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -45.2% over four weeks, -30.8% over 12 weeks, and 54.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.6%
4W-45.2%
12W-30.8%
26W45.3%
52W54.1%
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.65Latest activity-pressure read.
Pressure change-151.5%Four-week change in activity pressure.
Leadership-0.66Latest relative-leadership reading.
RS change-100.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 83%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength93/100Blend of value, momentum, and quality. Underlying universe rank 8; rank 1 is best.
Value84/100Relative valuation strength. Underlying universe rank 17; rank 1 is best.
Quality70/100Profitability and accounting quality. Underlying universe rank 31; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework44/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
11.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
31.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
14.6%
Gross profit retained from each unit of revenue.
Operating margin
2.7%
Operating profit retained from revenue.
Free-cash-flow margin
17.7%
Free cash flow generated from revenue.
Return on invested capital
7.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
25.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
515.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
9.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 48 relevant articles.

6 positive · 35 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings1dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-61.9%Distance below the 52-week high.
13-week volatility17.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+69.3%Week of 3 Apr.
Worst week-33.0%Week of 10 Jul.
Latest week-2.6%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains1
Flat weeks0
Modest losses3
Sharp losses12
Recent vol17.1%13-week weekly-return volatility.
Base vol15.2%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew14.3% / -7.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis76/100

Latest 12-week confirmation: trend 11/12, activity pressure 10/12, relative leadership 11/12.

Activity pressure 0.77; 2 reversal markers Factors82/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 10; Buyback Yield rank 65; Small Cap Core rank 16 SVQF44/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 564.5 of 1014 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 48 relevant articles.

VATE|Innovate Corp|Price:8.210|Chg%:+0.090 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings1d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20268.12 USD-2.6%9.60 USD7.95 USD-0.65-0.66515.9KOff
24 Jul 20268.34 USD-7.6%9.50 USD8.00 USD-0.313.57351.0KOn
17 Jul 20269.03 USD-9.1%9.39 USD8.05 USD0.3211.89559.6KOn
10 Jul 20269.93 USD-33.0%9.26 USD8.10 USD0.8421.87548.5KOn
3 Jul 202614.81 USD-23.3%9.08 USD8.16 USD1.2685.61398.9KOn
26 Jun 202619.31 USD-3.7%8.75 USD8.18 USD1.53152.271.2MOn
19 Jun 202620.06 USD20.0%8.28 USD8.16 USD1.55164.40393.5KOn
12 Jun 202616.72 USD-11.9%7.78 USD8.15 USD1.48130.18358.6KOn
5 Jun 202618.98 USD24.6%7.39 USD8.13 USD1.43169.87344.6KOn
29 May 202615.23 USD16.3%6.95 USD8.11 USD1.43118.19406.9KOn
22 May 202613.10 USD22.9%6.62 USD8.11 USD1.4394.54215.1KOn
15 May 202610.66 USD-9.1%6.37 USD8.11 USD1.5461.94277.4KOn
8 May 202611.73 USD-0.6%6.17 USD8.14 USD1.6580.20303.1KOn
1 May 202611.80 USD-9.2%5.93 USD8.17 USD1.6886.85268.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.